IPO Premiums
IPO calendar
GPListed

Gland Pharma Limited

Bookbuilding IPO · NSE, BSE

Price band
₹1490 - ₹1500
Lot size
10 shares
Issue amount
₹6,479.55 cr
Total subscription
0×
Current priceUnavailable
Listing price ₹1,710
Watch live price ↗
Opens
9 Nov 2020
Closes
11 Nov 2020
Allotment
18 Nov 2020
Listing
20 Nov 2020

Offer at a glance

Issue overview

Issue size
4,31,96,968 shares
Face value
₹1 per share
Minimum investment
₹14,900
Fresh issue
₹1,250 cr
Offer for sale
₹5,229.55 cr
Registrar
Link Intime India Private Limited
Listing exchange
NSE, BSE
Maximum investment
₹15,000
Issue type
Bookbuilding IPO
Shares before issue
15,49,49,490
Shares after issue
16,32,82,823

Lot sizes

CategoryLotsSharesAmount
RETAIL110₹15,000
sHNI14140₹2,10,000
bHNI67670₹10,05,000

Share reservation

QIB50%
HNI15%
RETAIL34%

Subscription & GMP

Subscription by category

Total subscribed0×

Subscription figures are awaiting publication.

GMP history

05911822 Dec: ₹118
22 Dec₹11822 Dec

Financial performance

Company financials

in Lakhs · Reported periods may include interim results.

Revenue & profitin Lakhs
010,00020,00030,000Mar-18 · Revenue: 16,716.82Mar-18 · Profit after tax: 3,210.51Mar-18Mar-19 · Revenue: 21,297.67Mar-19 · Profit after tax: 4,518.56Mar-19Mar-20 · Revenue: 27,724.08Mar-20 · Profit after tax: 7,728.58Mar-20June-20 · Revenue: 9,162.89June-20 · Profit after tax: 3,135.9June-20
RevenueProfit after tax

Company information

Company profile

Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.

Strengths

  • Wide range of complex injectable products.
  • Diversified B2B model with a growing B2C presence in India.
  • Advanced and scalable manufacturing capabilities.
  • Strong financial performance and consistent growth.
  • Led by an experienced and skilled management team.

Promoters

Fosun Pharma Industrial Pte. Ltd

Shanghai Fosun Pharmaceutical (Group) Co. Ltd

Registrar & documents

Lead manager

Citigroup Global Markets India Private Limited, Haitong Securities India Private Limited, Kotak Mahindra Capital Company Limited, Nomura Financial Advisory And Securities (India) Private Limited, Securities (India) Private Limited

Registered office

Sy. No. 143 - 148, 150 and 151, Near Gandi Maisamma 'X' Roads, D.P. Pally,Dundigal Medchal-Malkajgiri District, Hyderabad

+91 40 3051 0999

[email protected]Company website ↗

Frequently Asked Questions

What is Gland Pharma IPO GMP today?

As of today, Gland Pharma IPO Grey Market Premium (GMP) is reported at +₹118 per share. Based on the upper price band of ₹1,500, the estimated listing price is ₹1,618 (+7.9% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Gland Pharma IPO?

The minimum bid lot size for Gland Pharma IPO is 10 shares. At the cut-off price of ₹1,500 per share, retail investors need a minimum application amount of ₹15,000 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).

When will Gland Pharma IPO allotment status be announced?

The allotment status for Gland Pharma IPO is scheduled to be finalized on 18 Nov 2020. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Gland Pharma IPO allotment status online by PAN?

To check Gland Pharma IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Gland Pharma Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Gland Pharma IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums